Skip to main content

3-Year Review: Best & Worst ETFs In Each Asset Class

By: ETFdb
Over the last three years, Wall Street has witnessed a tremendous shift in the investment environment. Investors are slowly adopting riskier appetites as they continue to recover from the 2008 financial crisis, allowing bullish momentum to become a more dominant force in the markets. But while most asset classes have fared relatively well over the years, some have posted both hits and misses [see 25 Wild ETF Charts From 1H 2013]. Below, we highlight a handful of ETFs across each asset class that have surged over the past three years, as well as those that have struggled to keep up with Wall Street’s quick pace (note that inverse and leveraged ETFs are excluded from this list – data as of 7/23/13): Equity ETFs: Biotechs and Pharma Come Out on Top, Solar Struggles Though the Equity ETF space covers multiple industries, biotechnology-targeted funds have delivered stellar returns over the trailing 3-year period; [...] Click here to read the original article on ETFdb.com. Related Posts: Best ETF Performers Of 2010: Winners For Every ETFdb Category The Ultimate Guide To Currency ETF Trading Visual Guide To Investing In Preferred Stock ETFs CurrencyShares Singapore Dollar Trust (FXSG) Rolls Out Eric Dutram Talks New Safe Haven Currency ETFs On BNN
Over the last three years, Wall Street has witnessed a tremendous shift in the investment environment. Investors are slowly adopting riskier appetites as they continue to recover from the 2008 financial crisis, allowing bullish momentum to become a more dominant force in the markets. But while most asset classes have fared relatively well over the years, some have posted both hits and misses  [see 25 Wild ETF Charts From 1H 2013]. Below, we highlight a handful of ETFs across each asset class that have surged over the past three years, as well as those that have struggled to keep up with Wall Street’s quick pace (note that inverse and leveraged ETFs are excluded from this list – data as of 7/23/13): Equity ETFs: Biotechs and Pharma Come Out on Top, Solar Struggles Though the Equity ETF space covers multiple industries, biotechnology-targeted funds have delivered stellar returns over the trailing 3-year period; [...]

Click here to read the original article on ETFdb.com.

Related Posts:

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.